Possible enhancing effects of atrazine and nonylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats

Cancer Science

Volumn 95, Issue 5, 2004, Pages 404-410

  Fukamachi, Katsumi ^a   Seok Han, Beom ^a,b   Kyu Kim, Chuel ^a,b   Takasuka, Nobuo ^a   Matsuoka, Yoichiro ^a   Matsuda, Eiji ^a   Yamasaki, Tomomi ^c   Tsuda, Hiroyuki ^a,d  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b National Institute of Toxicological Research   (South Korea)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ATRAZINE; NONYLPHENOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BREAST ADENOCARCINOMA; BREAST ADENOMA; BREAST CARCINOGENESIS; BREAST TUMOR; CANCER INCIDENCE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DIETARY INTAKE; ENVIRONMENTAL EXPOSURE; FEEDING; FEMALE; IN VITRO STUDY; MALE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROTO ONCOGENE; RAT; SKIN TUMOR; SOYBEAN; STATISTICAL ANALYSIS; TRANSGENIC ANIMAL;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ADMINISTRATION, ORAL; ANIMAL FEED; ANIMALS; ANIMALS, GENETICALLY MODIFIED; ATRAZINE; BIOLOGICAL ASSAY; CARCINOGENS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENDOCRINE SYSTEM; FEMALE; GENES, RAS; GENETIC PREDISPOSITION TO DISEASE; HERBICIDES; HUMANS; MALE; MAMMARY NEOPLASMS, ANIMAL; PHENOLS; RATS; RISK ASSESSMENT;

EID: 3042591744     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2004.tb03223.x     Document Type: Article

References (64)

1. Daniel CW, Silberstein GB, Strickland P. Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res 1987; 47: 6052-7.
2. Russo J, Russo IH. Differentiation and breast cancer. Medicina (B Aires) 1997; 57: 81-91.
3. Henderson BE, Ross RK, Pike MC. Hormonal chemoprevention of cancer in women. Science 1993; 259: 633-8.
4. Feigelson HS, Henderson BE. Estrogens and breast cancer. Carcinogenesis 1996; 17: 2279-84.
5. Key TJ, Pike MC. The role of oestrogens and progestogens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988; 24: 29-43.
6. Henderson BE, Ross RK, Pike MC. Toward the primary prevention of cancer. Science 1991; 254: 1131-8.
7. Hulka BS, Liu ET, Lininger RA. Steroid hormones and risk of breast cancer. Cancer 1994; 74: 1111-24.
8. Eldridge JC, Tennant MK, Wetzel LT, Breckenridge CB, Stevens JT. Factors affecting mammary tumor incidence in chlorotriazine-treated female rats: hormonal properties, dosage, and animal strain. Environ Health Perspect 1994; 102 Suppl 11: 29-36.
9. Cooper RL, Stoker TE, Goldman JM, Parrish MB, Tyrey L. Effect of atrazine on ovarian function in the rat. Reprod Toxicol 1996; 10: 257-64.
10. Eldridge JC, Wetzel LT, Stevens JT, Simpkins JW. The mammary tumor response in triazine-treated female rats: a threshold-mediated interaction with strain and species-specific reproductive senescence. Steroids 1999; 64: 672-8.
11. Eldridge JC, Wetzel LT, Tyrey L. Estrous cycle patterns of Sprague-Dawley rats during acute and chronic atrazine administration. Reprod Toxicol 1999; 13: 491-9.
12. Cooper RL, Stoker TE, Tyrey L, Goldman JM, McElroy WK. Atrazine disrupts the hypothalamic control of pituitary-ovarian function. Toxicol Sci 2000; 53: 297-307.
13. Cummings AM, Rhodes BE, Cooper RL. Effect of atrazine on implantation and early pregnancy in 4 strains of rats. Toxicol Sci 2000; 58: 135-43.
14. Kniewald J, Jakominic M, Tomljenovic A, Simic B, Romac P, Vranesic D, Kniewald Z. Disorders of male rat reproductive tract under the influence of atrazine. J Appl Toxicol 2000; 20: 61-8.
15. Hayes TB, Collins A, Lee M, Mendoza M, Noriega N, Stuart AA, Vonk A. Hermaphroditic, demasculinized frogs after exposure to the herbicide atrazine at low ecologically relevant doses. Proc Natl Acad Sci USA 2002; 99: 5476-80.
16. Wetzel LT, Luempert LG 3rd, Breckenridge CB, Tisdel MO, Stevens JT, Thakur AK, Extrom PJ, Eldridge JC. Chronic effects of atrazine on estrus and mammary tumor formation in female Sprague-Dawley and Fischer 344 rats. J Toxicol Environ Health 1994; 43: 169-82.
17. Stevens JT, Breckenridge CB, Wetzel LT, Gillis JH, Luempert LG 3rd, Eldridge JC. Hypothesis for mammary tumorigenesis in Sprague-Dawley rats exposed to certain triazine herbicides. J Toxicol Environ Health 1994; 43: 139-53.
18. Stevens JT, Breckenridge CB, Wetzel L, Thakur AK, Liu C, Werner C, Luempert LG 3rd, Eldridge JC. Risk characterization for atrazine: oncogenicity profile. J Toxicol Environ Health A 1998; 55: 101-41.
19. Stevens JT, Breckenridge CB, Wetzel L. A risk characterization for atrazine: oncogenicity profile. J Toxicol Environ Health A 1999; 56: 69-109.
20. IARC. IARC monographs on the evaluation of carcinogenic risks to humans, atrazine. In: IARC monogr eval carcinog risks hum. vol. 73. Lyon: International Agency for Research on Cancer; 1999. p. 59-113.
21. Naylor GC, Mierure JP, Weeks JA, Castaldi FJ, Romano RR. Alkylphenol ethoxylates in the enviroment. J Am Oil Chemists Soc 1992; 69: 695-703.
22. Ahel M, Conrad J, Giger W. Persistent organic chemicals in sewage effluents. III. Determination of nonylphenoxy carboxylic acids by high resolution gas chromatography/mass spectrometry and high-performance liquid chromatography. Environ Sci Technol 1987; 21: 697-703.
23. Giger W, Ahel M, Koch M, Laubscher HU, Schaffner C, Schneider J. Behaviour of alkylphenol-polyethoxylate surfactants and of nitriloacatate in sewage treatment. Water Sci Technol 1987; 19: 449-60.
24. Soto AM, Justicia H, Wray JW, Sonnenschein C. p-Nonylphenol: an estrogenic xenobiotic released from "modified" polystyrene. Environ Health Perspect 1991; 92: 167-73.
25. White R, Jobling S, Hoare SA, Sumpter JP, Parker MG. Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology 1994; 135: 175-82.
26. Flouriot G, Pakdel F, Ducouret B, Valotaire Y. Influence of xenobiotics on rainbow trout liver estrogen receptor and vitellogenin gene expression. J Mol Endocrinol 1995; 15: 143-51.
27. Arukwe A, Knudsen FR, Goksoyr A. Fish zona radiata (eggshell) protein: a sensitive biomarker for environmental estrogens. Environ Health Perspect 1997; 105: 418-22.
28. Sonnenschein C, Soto AM. An updated review of environmental estrogen and androgen mimics and antagonists. J Steroid Biochem Mol Biol 1998; 65: 143-50.
29. Son HY, Nishikawa A, Ikeda T, Furukawa F, Hirose M. Lack of modification by environmental estrogenic compounds of thyroid carcinogenesis in ovariectomized rats pretreated with N-bis(2-hydroxypropyl)nitrosamine (DHPN). Jpn J Cancer Res 2000; 91: 966-72.
30. Son HY, Nishikawa A, Ikeda T, Nakamura H, Miyauchi M, Imazawa T, Furukawa F, Hirose M. Lack of modifying effects of environmental estrogenic compounds on the development of thyroid proliferative lesions in male rats pretreated with N-bis(2-hydroxypropyl)nitrosamine (DHPN). Jpn J Cancer Res 2000; 91: 899-905.
31. Tanaka T, Kohno H, Tanino M, Yanaida Y. Inhibitory effects of estrogenic compounds, 4-nonylphenol and genistein, on 7,12-dimethylbenz[a]anthracene-induced ovarian carcinogenesis in rats. Ecotoxicol Environ Saf 2002; 52: 38-45.
32. Asamoto M, Ochiya T, Toriyama-Baba H, Ota T, Sekiya T, Terada M, Tsuda H. Transgenic rats carrying human c-Ha-ras proto-oncogenes are highly susceptible to N-methyl-N-nitrosourea mammary carcinogenesis. Carcinogenesis 2000; 21: 243-9.
33. Tsuda H, Asamoto M, Ochiya T, Toriyama-Baba H, Naito A, Ota T, Sekiya T, Terada M. High susceptibility of transgenic rats carrying the human c-Ha-ras proto-oncogene to chemically-induced mammary carcinogenesis. Mutat Res 2001; 477: 173-82.
34. Ota T, Asamoto M, Toriyama-Baba H, Yamamoto F, Matsuoka Y, Ochiya T, Sekiya T, Terada M, Akaza H, Tsuda H. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis. Carcinogenesis 2000; 21: 1391-6.
35. Asamoto M, Toriyama-Baba H, Ohnishi T, Naito A, Ota T, Ando A, Ochiya T, Tsuda H. Transgenic rats carrying human c-Ha-ras proto-oncogene are highly susceptible to N-nitrosomethylbenzylamine induction of esophageal tumorigenesis. Jpn J Cancer Res 2002; 93: 744-51.
36. Park CB, Fukamachi K, Takasuka N, Han BS, Kim CK, Hamaguchi T, Fujita K, Ueda S and Tsuda H. Rapid induction of skin and mammary tumors in human c-Ha-ras proto-oncogene transgenic rats by treatment with 7,12-dimethylbenz[a]anthracene followed by 12-O-tetradecanoylphorbol 13-acetate. Cancer Sci 2004; 95: in press.
37. Han BS, Fukamachi K, Takasuka N, Ohnishi T, Maeda M, Yamasaki T, Tsuda H. Inhibitory effects of 17beta-estradiol and 4-n-octylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats. Carcinogenesis 2002; 23: 1209-15.
38. Squartini F, Pingitore R. Tumors of the mammary gland. In: Turusov VS, Turusov MU, editors. Pathology of tumors in laboratory animals. vol. 2. Lyon: International Agency for Research on Cancer; 1996. p. 47-100.
39. Boorman GA, Wilson JT, Van Zwieten MJ, Eustis SL. Mammary gland. In: Boorman GA, Eustis SL, Elwell MR, Montgomery CA Jr, Mackenzie WF, editors. Pathology of the Fischer rat. San Diego: Academic Press; 1990. p. 295-313.
40. Sakai A. p-Nonylphenol acts as a promoter in the BALB/3T3 cell transformation. Mutat Res 2001; 493: 161-6.
41. Tennant MK, Hill DS, Eldridge JC, Wetzel LT, Breckenridge CB, Stevens JT. Chloro-s-triazine antagonism of estrogen action: limited interaction with estrogen receptor binding. J Toxicol Environ Health 1994; 43: 197-211.
42. Tennant MK, Hill DS, Eldridge JC, Wetzel LT, Breckenridge CB, Stevens JT. Possible antiestrogenic properties of chloro-s-triazines in rat uterus. J Toxicol Environ Health 1994; 43: 183-96.
43. Connor K, Howell J, Chen I, Liu H, Berhane K, Sciarretta C, Safe S, Zacharewski T. Failure of chloro-S-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro. Fundam Appl Toxicol 1996; 30: 93-101.
44. Sanderson JT, Letcher RJ, Heneweer M, Giesy JP, van den Berg M. Effects of chloro-s-triazine herbicides and metabolites on aromatase activity in various human cell lines and on vitellogenin production in male carp hepatocytes. Environ Health Perspect 2001; 109: 1027-31.
45. Kniewald J, Mildner P, Kniewald Z. Effects of s-triazine herbicides on hormone-receptor complex formation, 5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase activity at the anterior pituitary level. J Steroid Biochem 1979; 11: 833-8.
46. Babic-Gojmerac T, Kniewald Z, Kniewald J. Testosterone metabolism in neuroendocrine organs in male rats under atrazine and deethylatrazine influence. J Steroid Biochem 1989; 33: 141-6.
47. Cooper RL, Goldman JM, Stoker TE. Neuroendocrine and reproductive effects of contemporary-use pesticides. Toxicol Ind Health 1999; 15: 26-36.
48. Pinter A, Torok G, Borzsonyi M, Surjan A, Csik M, Kelecsenyi Z, Kocsis Z. Long-term carcinogenicity bioassay of the herbicide atrazine in F344 rats. Neoplasma 1990; 37: 533-44.
49. O'Connor JC, Plowchal DR, Van Pelt CS, Davis LG, Cook JC. Role of prolactin in chloro-S-triazine rat mammary tumorigenesis. Drug Chem Toxicol 2000; 23: 575-601.
50. Schroeder JC, Olshan AF, Baric R, Dent GA, Weinberg CR, Yount B, Cerhan JR, Lynch CF, Schuman LM, Tolbert PE, Rothman N, Cantor KP, Blair A. Agricultural risk factors for t(14;18) subtypes of non-Hodgkin's lymphoma. Epidemiology 2001; 12: 701-9.
51. Hopenhayn-Rich C, Stump ML, Browning SR. Regional assessment of atrazine exposure and incidence of breast and ovarian cancers in Kentucky. Arch Environ Contam Toxicol 2002; 42: 127-36.
52. Van Leeuwen JA, Waltner-Toews D, Abernathy T, Smit B, Shoukri M. Associations between stomach cancer incidence and drinking water contamination with atrazine and nitrate in Ontario (Canada) agroecosystems, 1987-1991. Int J Epidemiol 1999; 28: 836-40.
53. Sathiakumar N, Delzell E. A review of epidemiologic studies of triazine herbicides and cancer. Crit Rev Toxicol 1997; 27: 599-612.
54. Kuch HM, Ballschmiter K. Determination of endocrine-disrupting phenolic compounds and estrogens in surface and drinking water by HRGC-(NCI)-MS in the picogram per liter range. Environ Sci Technol 2001; 35: 3201-6.
55. Laws SC, Carey SA, Ferrell JM, Bodman GJ, Cooper RL. Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats. Toxicol Sci 2000; 54: 154-67.
56. Asamoto M, Ota T, Toriyama-Baba H, Hokaiwado N, Naito A, Tsuda H. Mammary carcinomas induced in human c-Ha-ras proto-oncogene transgenic rats are estrogen-independent, but responsive to d-limonene treatment. Jpn J Cancer Res 2002; 93: 32-5.
57. Fehlberg S, Trautwein S, Goke A, Goke R. Bisphenol A diglycidyl ether induces apoptosis in tumour cells independently of peroxisome proliferator-activated receptor-gamma, in caspase-dependent and -independent manners. Biochem J 2002; 362: 573-8.
58. Tanaka T, Kohno H, Tanino M, Yanaida Y. Inhibitory effects of estrogenic compounds, 4-nonylphenol and genistein, on 7,12-dimethylbenz[a]anthracene-induced ovarian carcinogenesis in rats. Ecotoxicol Environ Saf 2002; 52: 38-45.
59. Takagi H, Mitsumori K, Onodera H, Nasu M, Tamura T, Yasuhara K, Takegawa K, Hirose M. Improvement of a two-stage carcinogenesis model to detect modifying effects of endocrine disrupting chemicals on thyroid carcinogenesis in rats. Cancer Lett 2002; 178: 1-9.
60. Kohno H, Tsukio Y, Yanaida Y, Tanino M, Tanaka T. Lack of modifying effects of 4-n-octylphenol on 3,2′-dimethyl-4-aminobiphenyl-induced prostate carcinogenesis in rats. Ecotoxicol Environ Saf 2002; 51: 210-5.
61. Katsuda S, Yoshida M, Kuroda H, Ando J, Takahashi M, Kurokawa Y, Watanabe G, Taya K, Maekawa A. Uterine adenocarcinoma in N-ethyl-N′-nitro-N-nitrosoguanidine-treated rats with high-dose exposure to p-tert-octylphenol during adulthood. Jpn J Cancer Res 2002; 93: 117-24.
62. Miles CJ, Pfeuffer RJ. Pesticides in canals of South Florida. Arch Environ Contam Toxicol 1997; 32: 337-45.
63. WHO. WHO recommendations. In: Guidelines for drinking water quality. vol. 1. Geneva: WHO; 1993. p. 77-8.
64. Ying GG, Williams B, Kookana R. Environmental fate of alkylphenols d alkylphenol ethoxylates-a review. Environ Int 2002; 28: 215-26.